N-Nitroso Edoxaban Impurity 4
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs .N-Nitroso Edoxaban Impurity 4 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Impurity 4 chemically represented as 2-bromo-5-nitroso-4,5,6,7- tetrahydrothiazolo[5,4-c] pyridine . Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Impurity 4 .We supply N-Nitroso Edoxaban Impurity 4 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-E39241 |
| CAS No | NA |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39242 |
| CAS No | NA |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39243 |
| CAS No | NA |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39244 |
| CAS No | NA |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39245 |
| CAS No | NA |
| Mol.F. | C14H25N3O4 |
| Mol.Wt. | 299.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39246 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O5S |
| Mol.Wt. | 564.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39247 |
| CAS No | NA |
| Mol.F. | C24H30ClN7O5S |
| Mol.Wt. | 564.1g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39248 |
| CAS No | 1353893-25-0 |
| Mol.F. | C14H27N3O3 |
| Mol.Wt. | 285.4g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39249 |
| CAS No | NA |
| Mol.F. | C23H27ClN8O6S |
| Mol.Wt. | 579g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39250 |
| CAS No | 480451-98-7 |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39251 |
| CAS No | 480450-71-3 |
| Mol.F. | C17H27N5O2S |
| Mol.Wt. | 365.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39252 |
| CAS No | 2024614-21-7 |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39253 |
| CAS No | 1255529-33-9 |
| Mol.F. | C21H30ClN5O5 |
| Mol.Wt. | 468g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39254 |
| CAS No | 500572-10-1 |
| Mol.F. | C24H30ClN7O4S : C7H8O3S |
| Mol.Wt. | 548.1 : 172.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39255 |
| CAS No | 480450-70-2 |
| Mol.F. | C17H25N7O2S |
| Mol.Wt. | 391.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-E39256 |
| CAS No | NA |
| Mol.F. | C26H46N4O7 |
| Mol.Wt. | 526.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |